NCT03929718View on ClinicalTrials.gov

Efficacy of Aldosterone Antagonist Therapy for Prevention of New Atrial Fibrillation

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 24, 2019

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2027

Conditions
AFib
Interventions
DRUG

Spironolactone

receive spironolactone treatment after CTI ablation

DRUG

No Spironolactone

no spironolactone treatment

Trial Locations (1)

30309

Piedmont Heart Institute, Atlanta

Sponsors
All Listed Sponsors
lead

Piedmont Healthcare

OTHER